<DOC>
	<DOC>NCT00442468</DOC>
	<brief_summary>The study does not involve testing of a drug (no treatment intervention). The study will will use spirometry (breathing tests) in subjects of 40 years of age and older with a history of cigarette smoking with chronic bronchitis to check their disease status and whether or not they have COPD. Also, study subjects will be asked to complete a questionnaire (to answer a list of questions on paper).</brief_summary>
	<brief_title>Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Bronchitis, Chronic</mesh_term>
	<criteria>Male or female ≥40 years of age Current or previous cigarette smoker with a history of cigarette smoking of ≥10 pack/years Self reported symptoms of chronic bronchitis where chronic bronchitis is defined as the presence of productive cough for at least 3 months in each of the successive 2 years Completion of written informed consent prior to study participation Subject must be able to read, comprehend, and record information in English. Regular use (i.e., prescribed for use on a daily basis) of the following respiratory medications for the six months prior to the study visit: ipratropium, ipratropium/albuterol combinations, tiotropium, salmeterol, formoterol, inhaled corticosteroids, inhaled corticosteroid/longacting betaagonist combinations, theophyllines, oral betaagonists. Previous lung surgery, including, lung transplant, lung resection, lung volume reduction surgery, etc. Current diagnosis of a significant lung condition other than chronic bronchitis, including, asthma, lung cancer, cystic fibrosis, pulmonary fibrosis, bronchiectasis, active tuberculosis, sarcoidosis, or alpha1antitrypsin deficiency. Any medical or physical condition that would interfere with the adequate performance of spirometry. Evaluation and/or treatment by a pulmonary specialist (e.g., pulmonologist or allergist) within 3 years of the study visit. A spirometrically confirmed diagnosis of COPD. Have, in the opinion of the investigator, evidence of current alcohol, illegal drug or solvent abuse. Limited ability to provide a valid informed consent due to serious uncontrolled psychiatric disease, intellectual or cognitive deficiency, poor motivation or other relevant condition which in the opinion of the site principal investigator will interfere with the subject's participation in the study. Pregnant females. Participating investigator, subinvestigator, study coordinator, employee of the participating investigator or family members of the aforementioned site staffs.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease (COPD)</keyword>
	<keyword>Chronic Bronchitis</keyword>
	<keyword>Spirometry</keyword>
</DOC>